AAI Cautions FTC On Carmark-Express Scripts Union

Law360, New York (February 16, 2007, 12:00 AM EST) -- Following up on its previous warnings, an antitrust think tank has warned the Federal Trade Commission that a merger between pharmaceutical benefit top guns Caremark Rx Inc. and Express Scripts Inc. would further stifle an already concentrated market and make it harder for small companies to break into the market.

“An Express Scripts/Caremark merger must be considered within the context of an industry plagued with substantial allegations of fraudulent, deceptive and anti-competitive conduct,” the American Antitrust Institute said in a letter sent on Wednesday.

A union...
To view the full article, register now.